It has been proposed that, by using this method, the presence of prion protein (PrP) in CSF of patients with human prion diseases can be determined with high accuracy, although it requires extended analysis times (up to 96 h) (Barria et al., 2018). This evidence concerns the gene PRNP and prion disease.